Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Opportunities and challenges of bi-specific antibodies.
Int Rev Cell Mol Biol. 2022;369:45-70. doi: 10.1016/bs.ircmb.2022.05.001. Epub 2022 May 30.
Int Rev Cell Mol Biol. 2022.
PMID: 35777864
Review.
Advances in mRNA-based drug discovery in cancer immunotherapy.
Di Trani CA, Fernandez-Sendin M, Cirella A, Segués A, Olivera I, Bolaños E, Melero I, Berraondo P.
Di Trani CA, et al. Among authors: segues a.
Expert Opin Drug Discov. 2022 Jan;17(1):41-53. doi: 10.1080/17460441.2021.1978972. Epub 2021 Sep 20.
Expert Opin Drug Discov. 2022.
PMID: 34496689
Review.
Item in Clipboard
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.
Di Trani CA, Cirella A, Arrizabalaga L, Alvarez M, Bella Á, Fernandez-Sendin M, Russo-Cabrera JS, Gomar C, Ardaiz N, Teijeira A, Bolaños E, González-Gomariz J, Otano I, Aranda F, Palencia B, Segués A, Huang S, van Duijnhoven SMJ, van Elsas A, Melero I, Berraondo P.
Di Trani CA, et al. Among authors: segues a.
Mol Ther Nucleic Acids. 2023 Jul 19;33:599-616. doi: 10.1016/j.omtn.2023.07.020. eCollection 2023 Sep 12.
Mol Ther Nucleic Acids. 2023.
PMID: 37637207
Free PMC article.
Item in Clipboard
Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies.
Segués A, van Duijnhoven SMJ, Parade M, Driessen L, Vukovic N, Zaiss D, Sijts AJAM, Berraondo P, van Elsas A.
Segués A, et al.
J Immunol Methods. 2021 Dec;499:113173. doi: 10.1016/j.jim.2021.113173. Epub 2021 Oct 24.
J Immunol Methods. 2021.
PMID: 34699840
Item in Clipboard
Shortened Hinge Design of Fab x sdAb-Fc Bispecific Antibodies Enhances Redirected T-Cell Killing of Tumor Cells.
Huang S, Segués A, Waterfall M, Wright D, Vayssiere C, van Duijnhoven SMJ, van Elsas A, Sijts AJAM, Zaiss DM.
Huang S, et al. Among authors: segues a.
Biomolecules. 2022 Sep 21;12(10):1331. doi: 10.3390/biom12101331.
Biomolecules. 2022.
PMID: 36291540
Free PMC article.
Item in Clipboard
Mouse IgG2a Isotype Therapeutic Antibodies Elicit Superior Tumor Growth Control Compared with mIgG1 or mIgE.
Vukovic N, Segués A, Huang S, Waterfall M, Sijts AJAM, Zaiss DM.
Vukovic N, et al. Among authors: segues a.
Cancer Res Commun. 2023 Jan 23;3(1):109-118. doi: 10.1158/2767-9764.CRC-22-0356. eCollection 2023 Jan.
Cancer Res Commun. 2023.
PMID: 36968226
Free PMC article.
Item in Clipboard
A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
Huang S, Segués A, Hulsik DL, Zaiss DM, Sijts AJAM, van Duijnhoven SMJ, van Elsas A.
Huang S, et al. Among authors: segues a.
J Immunol Methods. 2020 Aug;483:112811. doi: 10.1016/j.jim.2020.112811. Epub 2020 Jun 19.
J Immunol Methods. 2020.
PMID: 32569598
Free article.
Item in Clipboard
Cite
Cite